CDC reports 2022 ACIP recommendations for cholera vaccine use

This is a CDC report summarizing the 2022 recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding the use of cholera vaccine. The publication type is listed as 'OTHER', and it does not present new research data. Key methodological details such as study type, population, sample size, setting, comparator, and follow-up duration are not reported.

The report's main finding is the presentation of the ACIP recommendations. No specific numerical results, primary or secondary outcomes, or comparative efficacy data are provided within this summary. The safety and tolerability profile of the vaccine, including adverse events, serious adverse events, and discontinuation rates, are also not reported in the available information.

A key limitation is the absence of the underlying evidence review that informed the ACIP recommendations. The funding sources and potential conflicts of interest are not reported. For clinical practice, this serves as an announcement of updated guidance. Healthcare providers should refer to the complete CDC Morbidity and Mortality Weekly Report (MMWR) publication for the full rationale, specific indications, dosing schedules, and detailed recommendations to guide patient care.